A M Larson

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi request reprint Hepatitis C in clinical practice
    A M Larson
    Department of Medicine, University of Washington, Seattle 98195 6174, USA
    J Intern Med 249:111-20. 2001
  2. ncbi request reprint Integrating palliative care for liver transplant candidates: "too well for transplant, too sick for life"
    Anne M Larson
    Department of Medicine, School of Medicine, University of Washington, Seattle 98195 6174, USA
    JAMA 295:2168-76. 2006
  3. ncbi request reprint Liver disease in hereditary hemorrhagic telangiectasia
    Anne M Larson
    Department of Medicine, University of Washington, Seattle, 98195 6174, USA
    J Clin Gastroenterol 36:149-58. 2003
  4. ncbi request reprint Pilot study of the relationship between histologic progression and hepatic iron concentration in chronic hepatitis C
    Anne M Larson
    Division of Gastroenterology, University of Washington, Seattle, WA 98195, USA
    J Clin Gastroenterol 37:406-11. 2003
  5. ncbi request reprint Acetaminophen hepatotoxicity
    Anne M Larson
    Division of Gastroenterology, Hepatology Section, University of Washington, 1959 NE Pacific Street, Box 356174, Seattle, WA 98195 6174, USA
    Clin Liver Dis 11:525-48, vi. 2007
  6. ncbi request reprint Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study
    Anne M Larson
    Department of Internal Medicine, Division of Gastroenterology, University of Washington Medical Center, Seattle, 98195, USA
    Hepatology 42:1364-72. 2005
  7. ncbi request reprint Endotheliitis in chronic viral hepatitis: a comparison with acute cellular rejection and non-alcoholic steatohepatitis
    Matthew M Yeh
    Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98195 6100, USA
    Am J Surg Pathol 30:727-33. 2006
  8. ncbi request reprint The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases
    Matthew M Yeh
    Department of Pathology, School of Medicine, University of Washington, Seattle, WA 98195 6100, USA
    Am J Surg Pathol 31:681-9. 2007
  9. ncbi request reprint Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction
    Deborah L Diamond
    Department of Microbiology, University of Washington, Seattle, WA 98195 8070, USA
    Hepatology 46:649-57. 2007
  10. pmc Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure
    William M Lee
    Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8887, USA
    Gastroenterology 137:856-64, 864.e1. 2009

Collaborators

Detail Information

Publications25

  1. ncbi request reprint Hepatitis C in clinical practice
    A M Larson
    Department of Medicine, University of Washington, Seattle 98195 6174, USA
    J Intern Med 249:111-20. 2001
    ..By understanding the correct use of hepatitis C virus diagnostic testing and the risk and benefits of antiviral therapy, providers will be better equipped to screen and counsel their patients...
  2. ncbi request reprint Integrating palliative care for liver transplant candidates: "too well for transplant, too sick for life"
    Anne M Larson
    Department of Medicine, School of Medicine, University of Washington, Seattle 98195 6174, USA
    JAMA 295:2168-76. 2006
    ..In all of these circumstances, the health care team must combine elements of palliative care with life-sustaining therapy to maximize the patient's quality and quantity of life...
  3. ncbi request reprint Liver disease in hereditary hemorrhagic telangiectasia
    Anne M Larson
    Department of Medicine, University of Washington, Seattle, 98195 6174, USA
    J Clin Gastroenterol 36:149-58. 2003
    ..Embolization of large arteriovenous malformations in the liver remains controversial; however, liver transplantation can successfully eradicate these complications...
  4. ncbi request reprint Pilot study of the relationship between histologic progression and hepatic iron concentration in chronic hepatitis C
    Anne M Larson
    Division of Gastroenterology, University of Washington, Seattle, WA 98195, USA
    J Clin Gastroenterol 37:406-11. 2003
    ..The interaction between progression of hepatitis C and iron deposition warrants further study...
  5. ncbi request reprint Acetaminophen hepatotoxicity
    Anne M Larson
    Division of Gastroenterology, Hepatology Section, University of Washington, 1959 NE Pacific Street, Box 356174, Seattle, WA 98195 6174, USA
    Clin Liver Dis 11:525-48, vi. 2007
    ..Liver transplantation can be lifesaving for those who develop acute liver failure...
  6. ncbi request reprint Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study
    Anne M Larson
    Department of Internal Medicine, Division of Gastroenterology, University of Washington Medical Center, Seattle, 98195, USA
    Hepatology 42:1364-72. 2005
    ..Susceptible patients have concomitant depression, chronic pain, alcohol or narcotic use, and/or take several preparations simultaneously. Education of patients, physicians, and pharmacies to limit high-risk use settings is recommended...
  7. ncbi request reprint Endotheliitis in chronic viral hepatitis: a comparison with acute cellular rejection and non-alcoholic steatohepatitis
    Matthew M Yeh
    Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98195 6100, USA
    Am J Surg Pathol 30:727-33. 2006
    ....
  8. ncbi request reprint The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases
    Matthew M Yeh
    Department of Pathology, School of Medicine, University of Washington, Seattle, WA 98195 6100, USA
    Am J Surg Pathol 31:681-9. 2007
    ....
  9. ncbi request reprint Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction
    Deborah L Diamond
    Department of Microbiology, University of Washington, Seattle, WA 98195 8070, USA
    Hepatology 46:649-57. 2007
    ....
  10. pmc Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure
    William M Lee
    Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8887, USA
    Gastroenterology 137:856-64, 864.e1. 2009
    ..N-acetylcysteine (NAC), an antidote for acetaminophen poisoning, might benefit patients with non-acetaminophen-related acute liver failure...
  11. pmc False positive acetaminophen concentrations in patients with liver injury
    Julie Polson
    Department of Internal Medicine, University of Texas Southwestern Medical Center, 5959 Harry Hines Boulevard, Dallas, TX 75390, USA
    Clin Chim Acta 391:24-30. 2008
    ..However, recent case reports have suggested that acetaminophen concentrations may be falsely increased in the presence of hyperbilirubinemia...
  12. ncbi request reprint Liver histology and alanine aminotransferase levels in children and adults with chronic hepatitis C infection
    Karen F Murray
    Division of Gastroenterology and Nutrition, Department of Pediatrics, Children s Hospital and Regional Medical Center, Seattle, WA 98195 6174, USA
    J Pediatr Gastroenterol Nutr 41:634-8. 2005
    ..Chronic hepatitis C is often a mild disease in children, but whether this is related to younger age or shorter duration of infection is unclear. Histologic severity has been shown to correlate with duration of infection regardless of age...
  13. ncbi request reprint The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon
    S J Polyak
    Virology Division, University of Washington, Seattle, WA 98104 2499, USA
    J Infect Dis 182:397-404. 2000
    ..The PePHD is highly conserved in HCV-1-infected IFN responders and nonresponders and does not appear to evolve in response to IFN therapy...
  14. pmc Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes
    Ryan M Taylor
    Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109 0362, USA
    Hepatology 44:1589-97. 2006
    ....
  15. doi request reprint Role of liver transplantation in acute liver failure
    Iris W Liou
    Division of Gastroenterology, University of Washington, Seattle, WA, USA
    Semin Liver Dis 28:201-9. 2008
    ..There are many ethical and psychosocial issues inherent to transplanting these sick patients due to the urgent nature of acute liver failure. Fortunately, the long-term survival and quality of life in these transplant recipients is good...
  16. ncbi request reprint Elevated troponin I levels in acute liver failure: is myocardial injury an integral part of acute liver failure?
    Nimisha K Parekh
    Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    Hepatology 45:1489-95. 2007
    ..Measurement of troponin I levels may be helpful in patients with acute liver failure, to detect unrecognized myocardial damage and as a marker of unfavorable outcome...
  17. ncbi request reprint Temporary support for acute liver failure
    Pankaj Rajvanshi
    Division of Gastroenterology and Hepatology, University of Washington School of Medicine, Seattle, Washington 98195 6174, USA
    J Clin Gastroenterol 35:335-44. 2002
    ..Predefined outcomes from individual patients were synthesized collectively into tables...
  18. doi request reprint Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors
    Edie Y Chan
    Division of Transplantation, Department of Surgery, University of Washington, Seattle, WA 98195, USA
    Liver Transpl 14:604-10. 2008
    ..Careful donor selection may improve utilization of these grafts...
  19. ncbi request reprint Cardiopulmonary consequences of transjugular intrahepatic portosystemic shunts: role of increased pulmonary artery pressure
    Jonathan M Schwartz
    Department of Medicine, Gastroenterology Division, University of Washington, Seattle, WA, USA
    J Clin Gastroenterol 38:590-4. 2004
    ..To determine whether increased pulmonary artery pressure (PAP) following transjugular intrahepatic portosystemic shunting (TIPSS) results in short-term mortality or cardiorespiratory complications...
  20. ncbi request reprint Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients
    Edie Y Chan
    Division of Transplantation, Department of Surgery, University of Washington, Seattle, WA 98195, USA
    Liver Transpl 13:516-22. 2007
    ..037). In conclusion, we have identified liver transplant patients with AIH or the combination of ALD, HCC, and glucose intolerance who receive a steatotic donor liver as being at high risk for developing GVHD...
  21. ncbi request reprint Measurement of serum acetaminophen-protein adducts in patients with acute liver failure
    Timothy J Davern
    University of California at San Francisco, San Francisco, California, USA corrected
    Gastroenterology 130:687-94. 2006
    ..Measurement of serum adducts might improve diagnostic accuracy in acute liver failure (ALF) patients...
  22. doi request reprint Identifying risk for recurrent hepatocellular carcinoma after liver transplantation: implications for surveillance studies and new adjuvant therapies
    Edie Y Chan
    Division of Transplant Surgery, Department of General Surgery, Rush University Medical Center, Chicago, IL, USA
    Liver Transpl 14:956-65. 2008
    ..In conclusion, patients transplanted for HCC with a PCRS of < or =0 have a low risk of recurrence. Patients with a PCRS of 1 or 2 have a moderate risk of recurrence, and those with a PCRS of > or =3 have a high risk for recurrence...
  23. ncbi request reprint Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy
    Javier Vaquero
    Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Chicago, IL 60611, USA
    Liver Transpl 11:1581-9. 2005
    ..In view of the high 30-day survival rate after LT, future studies of the impact of intracranial hypertension should also focus on long-term neurological recovery from ALF...
  24. doi request reprint Acute liver failure
    Anne M Larson
    Dis Mon 54:457-85. 2008
  25. doi request reprint Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests
    Jessica D Korman
    Montefiore Medical Center, Bronx, NY, USA
    Hepatology 48:1167-74. 2008
    ..In addition, an AST:ALT ratio >2.2 yielded a sensitivity of 94%, a specificity of 86%, and a likelihood ratio of 7 for diagnosing fulminant WD. Combining the tests provided a diagnostic sensitivity and specificity of 100%...